267 related articles for article (PubMed ID: 31913347)
1. Nimesulide increases the aldehyde oxidase activity of humans and rats.
Zhou L; Pang XY; Hou XY; Liu L; Guo ZT; Chen XY
Acta Pharmacol Sin; 2020 Jun; 41(6):843-851. PubMed ID: 31913347
[TBL] [Abstract][Full Text] [Related]
2. Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: in vitro and pharmacoepidemiological approaches.
Moriyama A; Ueda H; Narumi K; Asano S; Furugen A; Saito Y; Kobayashi M
Expert Opin Drug Metab Toxicol; 2024 May; 20(5):399-406. PubMed ID: 38706380
[TBL] [Abstract][Full Text] [Related]
3. Nimesulide and 4'-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis.
Zhou L; Pang X; Jiang J; Zhong D; Chen X
Drug Metab Dispos; 2017 May; 45(5):441-448. PubMed ID: 28202577
[TBL] [Abstract][Full Text] [Related]
4. In vivo-in vitro relationship of methotrexate 7-hydroxylation by aldehyde oxidase in four different strain rats.
Moriyasu A; Sugihara K; Nakatani K; Ohta S; Kitamura S
Drug Metab Pharmacokinet; 2006 Dec; 21(6):485-91. PubMed ID: 17220564
[TBL] [Abstract][Full Text] [Related]
5. Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase.
Choughule KV; Joswig-Jones CA; Jones JP
Biochem Pharmacol; 2015 Aug; 96(3):288-95. PubMed ID: 26032640
[TBL] [Abstract][Full Text] [Related]
6. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
[TBL] [Abstract][Full Text] [Related]
7. Chemical and Enzymatic Transformations of Nimesulide to GSH Conjugates through Reductive and Oxidative Mechanisms.
Zhou L; Pang X; Xie C; Zhong D; Chen X
Chem Res Toxicol; 2015 Dec; 28(12):2267-77. PubMed ID: 26524229
[TBL] [Abstract][Full Text] [Related]
8. A rapid and sensitive fluorometric method for determination of aldehyde oxidase activity.
Apenova N; Peng H; Hecker M; Brinkmann M
Toxicol Appl Pharmacol; 2018 Feb; 341():30-37. PubMed ID: 29329804
[TBL] [Abstract][Full Text] [Related]
9. Effect of commonly used organic solvents on aldehyde oxidase-mediated vanillin, phthalazine and methotrexate oxidation in human, rat and mouse liver subcellular fractions.
Behera D; Pattem R; Gudi G
Xenobiotica; 2014 Aug; 44(8):722-33. PubMed ID: 24533630
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions.
Takaoka N; Sanoh S; Okuda K; Kotake Y; Sugahara G; Yanagi A; Ishida Y; Tateno C; Tayama Y; Sugihara K; Kitamura S; Kurosaki M; Terao M; Garattini E; Ohta S
Biochem Pharmacol; 2018 Aug; 154():28-38. PubMed ID: 29678521
[TBL] [Abstract][Full Text] [Related]
11. Developmental changes of aldehyde oxidase in postnatal rat liver.
Tayama Y; Moriyasu A; Sugihara K; Ohta S; Kitamura S
Drug Metab Pharmacokinet; 2007 Apr; 22(2):119-24. PubMed ID: 17495419
[TBL] [Abstract][Full Text] [Related]
12. Effects of Phenothiazines on Aldehyde Oxidase Activity Towards Aldehydes and N-Heterocycles: an In Vitro and In Silico Study.
Deris-Abdolahpour F; Abdolalipouran-Sadegh L; Dastmalchi S; Hamzeh-Mivehroud M; Zarei O; Dehgan G; Rashidi MR
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):275-286. PubMed ID: 30382490
[TBL] [Abstract][Full Text] [Related]
13. The importance of inhibition of a catabolic pathway of methotrexate metabolism in its efficacy for rheumatoid arthritis.
Morgan SL; Baggott JE
Med Hypotheses; 2019 Jan; 122():10-15. PubMed ID: 30593388
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Extrahepatic Aldehyde Oxidase Activity to Human Clearance.
Kozminski KD; Selimkhanov J; Heyward S; Zientek MA
Drug Metab Dispos; 2021 Sep; 49(9):743-749. PubMed ID: 34162687
[TBL] [Abstract][Full Text] [Related]
15. No influence of enzyme inhibitors on the hydroxylation of methotrexate in rats.
Yu D; Brasch H; Iven H
Cancer Lett; 1989 Nov; 48(2):153-6. PubMed ID: 2819703
[TBL] [Abstract][Full Text] [Related]
16. Strain differences of the ability to hydroxylate methotrexate in rats.
Kitamura S; Nakatani K; Sugihara K; Ohta S
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1999 Mar; 122(3):331-6. PubMed ID: 10336093
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues.
Hammid A; Fallon JK; Vellonen KS; Lassila T; Reinisalo M; Urtti A; Gonzalez F; Tolonen A; Smith PC; Honkakoski P
Eur J Pharm Sci; 2023 Dec; 191():106603. PubMed ID: 37827455
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review of in silico approaches for the prediction and modulation of aldehyde oxidase-mediated drug metabolism: The current features, challenges and future perspectives.
Soltani S; Hallaj-Nezhadi S; Rashidi MR
Eur J Med Chem; 2021 Oct; 222():113559. PubMed ID: 34119831
[TBL] [Abstract][Full Text] [Related]
20. Oxidative metabolism and pharmacokinetics of the EGFR inhibitor BIBX1382 in chimeric NOG-TKm30 mice transplanted with human hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Pharmacokinet; 2021 Dec; 41():100419. PubMed ID: 34624627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
